+44 (0) 1793 575 050
customerservice@regenmedical.co.uk

Part of the Joint Operations family

EpiFix has demonstrated in previous studies very high rates of healing, with the original study showing 90%+ rates of healing in DFU wounds and 71% in VLU wounds.

With studies looking at long term follow up and the overall time to closure using weekly applications v biweekly, MiMedx demonstrates the effectiveness of EpiFix in hard to heal/non-healing ulcers.

The latest study further demonstrates this in a wider group of patients across multiple centres:


MiMedx Clinical Evidence Review


New Multicentre DFU RCT

Get in touch to see how EpiFix can help your patients 

Call +44 (0) 1793 575 050 or email on customerservice@regenmedical.co.uk

MiMedx Clinical Evidence Review References